{"title":"症状、副作用、生活质量和经济毒性对癌症患者很重要,我们需要在试验和临床护理中更好地捕捉和报告这些概念。","authors":"Melanie Calvert, Roger Wilson, John Devin Peipert","doi":"10.1136/bmjonc-2025-000879","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":72436,"journal":{"name":"BMJ oncology","volume":"4 1","pages":"e000879"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182017/pdf/","citationCount":"0","resultStr":"{\"title\":\"Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical care.\",\"authors\":\"Melanie Calvert, Roger Wilson, John Devin Peipert\",\"doi\":\"10.1136/bmjonc-2025-000879\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":72436,\"journal\":{\"name\":\"BMJ oncology\",\"volume\":\"4 1\",\"pages\":\"e000879\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182017/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjonc-2025-000879\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjonc-2025-000879","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical care.